Niclosamide is an old antiparasitic with documented anticancer activity in laboratory models, but its clinical use for cancer has been limited by poor solubility and bioavailability. The authors ...

Calling all parents! If cold and flu season has wreaked havoc on your household this year, relief is near! There’s a new, ...

The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...

Harmony Biosciences has thrived due to the success of its Wakix narcolepsy treatment. Harmony is looking to extend the life ...

Speakers delved into innovative strategies in skin tumor management, focusing on chemotherapies, patient risk assessment, and evolving treatment protocols.

A Japanese research team has discovered a new compound that can advance the body's internal clock—offering hope for faster ...

Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026.

The field of metabolic disease therapeutics has experienced rapid advancement with the introduction of glucagon-like peptide-1 receptor agonists (GLP-1RAs), ...

Researchers will evaluate the IL1RAP-targeted nadunolimab with a checkpoint inhibitor in up to 24 metastatic microsatellite stable colorectal cancer patients.

Tirzepatide ( Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, ...

Testosterone is being sold as the missing hormone for midlife women. Except there's no FDA-approved female dose, so sourcing and dosing has become the Wild West. How did we get here, and what comes ...

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.